An update on PK/PD modeling
Chairman: G Kenny 

• Modern Pk/Pd modeling tools
  JM Bailey (US)
  
• Clinical application of pharmacokinetic and dynamic models
  V. Billard (FR)
  
• Recirculatory pharmacokinetics. Which physiological covariates affect the PK of IV agents?
  TK Henthorn (US)

Intraoperative (un)consciousness and postoperative cognitive function. 
Chairman: N. Sutcliffe

• Factors of influence on postoperative cognitive function in the elderly.
  L. Rasmussen (DEN)
  

• Awareness and anaesthesia. Incidence, monitoring and prevention.
  R. Sandin (S)

 Intravenous anaesthetics and respiratory dynamics 
Chairman: J. Vuyk

• Factors influencing the control of breathing
  A. Dahan (NL)
  

• Intravenous anaesthetics affect phrenic nerve activity 
  D. Ma (UK)
  

• Sex differences in morphine PK and respiratory dynamics 
  E.Y. Sarton (NL)

Update on neuromuscular relaxants.
Chairman: A. Borgeat

• The effect of anaesthetic agents on muscle relaxant behavior.
  R.K. Mirakhur (UK)
  
• Why does rapacuronium have a rapid on- and offset of action?
   J.M. Hunter (UK)
  
• Effect sites of NMBA and the monitoring of clinical muscle relaxation.
  C. Meistelman (Fr)

 Basic pharmacology and anaesthetic action Chairman: F. Servin

• What does ethanol do to the brain?
  TJ Feuerstein (Ger)
  
• Neuromodulatory action of endocannabinoids
  V. Di Marzo (I)
  
• Alpha-2-agonists; sedatives or analgesics? 
  R. Aantaa (Fin)

 Anaesthesia made visible
Chairman: F. Engbers

• PET-scanning  and propofol action  .
  P. Fiset (Can)
  
• Intravenous anaesthesia/analgesia, why do we need local anaesthetics?
  A. Borgeat (CH)
  
• Clinical evaluation of intravenous hypnotic-opioid combinations.
  The Eurosiva Multi-Media team